Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Poon

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
Cancer Research|October 19, 2006
Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transitionTerence K Lee, Kwan Man, Ronnie T P Poon, et al.
ANZ Journal of Surgery|October 6, 2012
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastasesTan To Cheung, Ronnie T P Poon, Wai Key Yuen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?Albert C Y Chan, See Ching Chan, Kenneth S H Chok, et al.
Digestive Diseases and Sciences|May 10, 2014
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2Felice H Tsang, Victor Au, Wen-Jing Lu, et al.
ANZ Journal of Surgery|July 2, 2013
Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective studyKenneth S H Chok, Tan To Cheung, Albert C Y Chan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathwaysKwan Man, Kevin T Ng, Chung Mau Lo, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 8, 2012
Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinomaTan To Cheung, See Ching Chan, Kenneth S H Chok, et al.
International Journal of Cancer|December 10, 2009
Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinomaNikki P Lee, Felice H Tsang, Felix H Shek, et al.
Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantationTan To Cheung, Kenneth S H Chok, Regina C L Lo, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
Cancer Research|October 19, 2006
Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transitionTerence K Lee, Kwan Man, Ronnie T P Poon, et al.
ANZ Journal of Surgery|October 6, 2012
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastasesTan To Cheung, Ronnie T P Poon, Wai Key Yuen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?Albert C Y Chan, See Ching Chan, Kenneth S H Chok, et al.
Digestive Diseases and Sciences|May 10, 2014
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2Felice H Tsang, Victor Au, Wen-Jing Lu, et al.
ANZ Journal of Surgery|July 2, 2013
Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective studyKenneth S H Chok, Tan To Cheung, Albert C Y Chan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathwaysKwan Man, Kevin T Ng, Chung Mau Lo, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 8, 2012
Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinomaTan To Cheung, See Ching Chan, Kenneth S H Chok, et al.
International Journal of Cancer|December 10, 2009
Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinomaNikki P Lee, Felice H Tsang, Felix H Shek, et al.
Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantationTan To Cheung, Kenneth S H Chok, Regina C L Lo, et al.
Pageof 23